TY  - GEN
AU  - Garcia-Aranda, Marilina
AU  - Tellez, Teresa
AU  - McKenna, Lauraine
AU  - Redondo, Maximino
PY  - 2022
DO  - 10.3390/cancers14092255
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/20890
T2  - Cancers
AB  - Nowadays, the identification of new therapeutic targets that allow for the development of treatments, which as monotherapy, or in combination with other existing treatments can contribute to improve response rates, prognosis and survival of oncologic...
LA  - en
PB  - MDPI AG
KW  - NK-1R
KW  - cancer
KW  - drug repurposing
KW  - personalized medicine
KW  - resistance
KW  - tachykinin
KW  - tachykinin receptor
KW  - targeted treatment
KW  - Substance P
KW  - Receptors, Neurokinin-1
KW  - Neoplasms
KW  - Drug Resistance, Neoplasm
KW  - Therapeutic Equivalency as Topic
KW  - Antineoplastic Agents, Targeted
TI  - Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance.
TY  - review
VL  - 14
ER  -